OviTex versus synthetic graft in robotic prolapse surgery (ProTex): rationale and study protocol of a multicentre, phase II and III, partially randomised patient preference trial

STRENGTHS AND LIMITATIONS OF THIS STUDY

  • Innovative use of a reinforced tissue matrix (OviTex) in pelvic prolapse procedures.

  • Patient-preference trial design enhances external validity.

  • Robust comparison with current clinical standard (polypropylene mesh).

  • The lack of blinding for outcome assessors, due to the obvious differences in surgical materials, may introduce bias.

  • The study is powered for functional outcomes (eg, constipation, incontinence) rather than recurrence, limiting conclusions on long-term anatomical success.

  • Background

    Minimal-invasive ventral mesh rectopexy (VMR) and sacrocolporectopexy (SCR) or cervicopexy are international standard treatments for patients suffering from pelvic prolapse.1 2 Choice of material used in VMR or SCR—synthetic mesh or reinforced tissue matrices (RTM)—remains subject of debate. The recent ban in the usage of transvaginal mesh for pelvic organ prolapse (POP) in April 2019, by the Food and Drug Administration has negatively influenced the perception…
    This post was originally published on https://bmjopen.bmj.com